Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats

INTRODUCTION: Doxorubicin (DOX) is a well-known anticancer drug. However its clinical use has been limited due to cardiotoxic effects. One of the major concerns with DOX therapy is its toxicity in patients who are frail, particularly diabetics. Several studies suggest that mesenchymal stem cells (MS...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Stem Cell Res Ther
Główni autorzy: Ammar, Hania Ibrahim, Sequiera, Glen Lester, Nashed, Mira B., Ammar, Rasha I., Gabr, Hala M., Elsayed, Hany E., Sareen, Niketa, Rub, Ejlal Abu-El, Zickri, Maha B., Dhingra, Sanjiv
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2015
Hasła przedmiotowe:
Research
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4546321/
https://ncbi.nlm.nih.gov/pubmed/26296856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0142-x
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy